ALLMedicine™ Lentigo Maligna Melanoma Center

Dec 21st, 2022 - Time trend analysis of cutaneous melanoma (CM) mortality in fair skin populations shows both a gradual decrease and/or an increase. To explain these differences, we analyzed long-term time trends in the incidence of the most common histological su...

Nov 14th, 2022 - Whether menopausal hormone therapy (MHT) increases the risk of skin cancer is controversial. To systematically review and meta-analyze evidence regarding the association of MHT with the risk of melanoma and keratinocyte cancer (KC). A comprehensiv...

Nov 12th, 2022 - Primary melanoma management relies on tumor extirpation and staging sentinel lymph node biopsy (SLNB) in eligible patients. This study compares SLNB utilization in patients undergoing wide local excision (WLE) or Mohs micrographic surgery (MMS). A...

Nov 11th, 2022 - Currently, there is no study that has reported on the seasonal trends of skin cancer in the Netherlands. This study aimed to investigate seasonal variation in diagnosis of cutaneous melanoma (CM) and cutaneous squamous cell carcinoma (cSCC) focusi...

Nov 3rd, 2022 - Facial skin is characterized by high density of follicles. Facial neoplasms may present overlapping clinical and dermoscopic findings. Our goal was to evaluate and compare, via reflectance confocal microscopy (RCM), follicular involvement in facia...

Oct 23rd, 2019 - Lentigo maligna (LM) is a subtype of melanoma in situ that usually occurs in sun-damaged skin and is characterised by an atypical proliferation of melanocytes within the basal epidermis. If left untreated, LM can develop into invasive melanoma, te...

May 30th, 2018 - Lentigo maligna (LM) is an in-situ form of melanoma which occurs on sun-exposed skin. Untreated LM can progress into invasive lentigo maligna melanoma (LMM). The incidence of LM/LMM is constantly increasing as the population grows older and lifelo...

Dec 5th, 2020 - Metastatic melanoma has limited treatment options, but advances in the understanding of the oncogenic mutations that drive this cancer and how the immune system can be better modulated to fight melanoma provide a new generation of active approache...

Nov 13th, 2020 - Pascale Guitera, MD, director, Sydney Melanoma Diagnostic Centre, associate professor, University of Sydney, discusses the RADICAL trial of patients with melanoma. The phase III multicenter RADICAL trial is investigating patients with lentigo mal...

Sep 4th, 2020 - The Melanoma Institute Australia (MIA) nomogram was found to accurately estimate the risk of sentinel node metastasis positivity in patients with melanoma and its use could help to reduce the rate of unnecessary invasive biopsies without sacrifici...

Sep 25th, 2019 - Mohs micrographic surgery was associated with improved survival compared with traditional excision in early invasive melanoma, a retrospective study indicated. Among more than 70,000 stage I patients in a national database, univariable analysis sh...

Mar 7th, 2019 - The FP suspected that this was a skin cancer with ulceration and pigmentation. The differential diagnosis included pigmented basal cell carcinoma, melanoma, and squamous cell carcinoma.